文献速递瓣膜病与结构性心脏病血脂与心血管预防

先天性心脏病患者植入右侧机械瓣膜假体后的结局

Outcomes after implantation of right-sided mechanical valve prostheses in congenital heart disease.
PubMed 文献 · Heart · 2023-11-10

该病例对照研究纳入先天性心脏病成人患者,比较机械瓣与生物瓣在肺动脉瓣位和/或三尖瓣位置换后的瓣膜功能及结局。机械瓣组瓣膜梯度随时间增加更低、瓣膜功能障碍风险更低,但大出血事件风险更高。

要点

  • 机械瓣在肺动脉瓣位和三尖瓣位均显示更低的瓣膜梯度进展。
  • 机械瓣的瓣膜功能障碍年发生率低于生物瓣。
  • 机械瓣的大出血事件年发生率高于生物瓣。

核心结论

  • 与右侧生物瓣相比,右侧机械瓣植入后瓣膜梯度随时间增加更低、瓣膜功能障碍风险更低,但出血并发症风险更高。

研究设计与样本

  • 病例对照研究,纳入2003-2021年在Mayo Clinic Rochester接受机械三尖瓣置换或肺动脉瓣置换的成人先天性心脏病患者,并按1:2匹配接受同位置生物瓣的患者。
  • 机械肺动脉瓣置换48例(年龄32(26-38)岁,男性22例(56%)),机械三尖瓣置换17例(年龄36(31-42)岁,男性9例(53%))。
  • 生物瓣肺动脉瓣置换对照组78例(年龄30(24-36)岁,男性44例(56%)),生物瓣三尖瓣置换对照组34例(年龄34(29-39)岁,男性18例(53%))。

主要发现

  • 机械瓣组肺动脉瓣置换后多普勒收缩期平均梯度随时间变化为∆ -1±2 mm Hg,生物瓣组为3±2 mm Hg(p<0.001)。
  • 机械瓣组三尖瓣置换后多普勒舒张期平均梯度随时间变化为∆ 0±1 mm Hg,生物瓣组为2±1 mm Hg(p=0.005)。
  • 机械瓣组肺动脉瓣置换后瓣膜功能障碍年发生率为1.0%,生物瓣组为2.8%(p=0.02)。
  • 机械瓣组三尖瓣置换后瓣膜功能障碍年发生率为2.6%,生物瓣组为4.3%(p=0.008)。
  • 机械瓣组大出血事件年发生率为2.2%,生物瓣组为0.1%(p<0.001)。

临床怎么用

  • 在先天性心脏病患者中考虑右侧瓣膜置换时,需权衡机械瓣的低瓣膜功能障碍风险与高出血风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Bioprosthetic valves are often used for pulmonary valve replacement (PVR) and tricuspid valve replacement (TVR) because of concerns about mechanical valve thrombosis in the right heart. The purpose of this study was to assess prosthetic valve function and outcomes (prosthetic valve dysfunction, reoperations and major bleeding events) after mechanical PVR and TVR and to compare these to bioprostheses implanted in the same positions. METHOD: Case-control study of adults with congenital heart disease that underwent mechanical TVR or PVR (2003-2021) at Mayo Clinic Rochester, Minnesota. For each mechanical prosthesis, we identified two patients that received bioprosthesis in the same position (1:2 matching). RESULTS: We identified 48 consecutive patients that underwent mechanical PVR (n=39, age 32 (26-38) years, men 22 (56%)) and/or mechanical TVR (n=17, age 36 (31-42) years, men 9 (53%)), as control group of 78 patients (age 30 (24-36) years, men 44 (56%)) and 34 patients (age 34 (29-39) years, men 18 (53%)) that underwent bioprosthetic PVR and TVR, respectively. The most common diagnoses in patients that received mechanical prosthesis were: tetralogy of Fallot (n=14, 19%), aortic stenosis status post Ross operation (n=11, 23%), truncus arteriosus (n=5, 11%), atrioventricular canal defect (n=4, 8%), Ebstein anomaly (n=3, 6%), double outlet right ventricle (n=2, 4%), valvular pulmonic stenosis (n=2, 4%). Compared with the bioprosthesis group, the mechanical prosthesis group had lower temporal increase in Doppler systolic mean gradient after PVR (∆ -1±2 vs 3±2 mm Hg, p<0.001) and Doppler diastolic mean gradient after TVR (∆ 0±1 vs 2±1 mm Hg, p=0.005). The mechanical prosthesis group also had lower risk of prosthetic valve dysfunction after PVR (1.0% vs 2.8% /year, p=0.02) and after TVR (2.6% vs 4.3% /year, p=0.008), but higher risk of major bleeding events (2.2% vs 0.1% /year, p<0.001). CONCLUSIONS: Patients that received right-sided mechanical valve prostheses had lower temporal increase in valve gradient, lower risk of prosthetic valve dysfunction, but higher risk of bleeding complications compared with those that underwent right-sided bioprosthetic valve implantation.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Abozied O, Miranda W, Younis A, et al. Outcomes after implantation of right-sided mechanical valve prostheses in congenital heart disease. Heart. 2023. PMID: 37407219. doi:10.1136/heartjnl-2023-322666

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。